High‐flow nasal cannula for stabilisation of very premature infants: A prospective observational study

• DOI: 10.1111/apa.17519
• Publication Date: 2024-11-25T12:38:13Z
• Authors: Klára Jonáš; Tereza Lamberská; Truong An Nguyen; Petr Kudrna; Richard Plavka
• Keywords: Nasal cannula; Oxygen Saturation

Abstract Aim To assess the feasibility, safety and efficacy of using a high‐flow nasal cannula (HFNC) for stabilising very preterm infants after birth. Methods A prospective observational study included born at 28 + 0 to 31 6 weeks' gestation between February 2021 December 2022 General University Hospital in Prague. Following delayed cord clamping, HFNC was administered flow rate 8 L/min through infants' nostrils. Criteria switching continuous positive airway pressure (CPAP) or ventilation (PPV) persistent bradycardia first few minutes low saturation oxygen (SpO 2 ) 5 min, respectively. Results Of 65 enrolled study, 56 (86%) were successfully stabilised exclusively while 7 (11%) required PPV. Additionally, 52 (80%) achieved SpO > 80% 54 (83%) treated with within 3 h life. Conclusion The primary use seems be an appropriate alternative CPAP stabilisation premature birth subsequent transfer NICU. randomised trial comparing delivery room will enable answer questions raised this study.